Summary of changes in clinical outcomes and provider adherence at 12 months
| . | Baseline . | 12 Months . |
|---|---|---|
| Clinical outcome measures | ||
| High-risk glycohemoglobin, HbA1c >9.5% | 10.9 | 3.1 |
| Members with drop in HbA1c ≥0.5% | — | 45.6 |
| Blood pressure <140/90 mmHg | 38.9 | 66.8 |
| Provider adherence measures | ||
| Lipid profile testing within the last 2 years | 66 | 100 |
| Microalbuminuria within the last year | 17 | 100 |
| Retinal eye exam within the last year | 53.9 | 80.3 |
| Foot exam with monofilament test within the last year | N/A | 100 |
| . | Baseline . | 12 Months . |
|---|---|---|
| Clinical outcome measures | ||
| High-risk glycohemoglobin, HbA1c >9.5% | 10.9 | 3.1 |
| Members with drop in HbA1c ≥0.5% | — | 45.6 |
| Blood pressure <140/90 mmHg | 38.9 | 66.8 |
| Provider adherence measures | ||
| Lipid profile testing within the last 2 years | 66 | 100 |
| Microalbuminuria within the last year | 17 | 100 |
| Retinal eye exam within the last year | 53.9 | 80.3 |
| Foot exam with monofilament test within the last year | N/A | 100 |
Data are %.